N/A Completed N=150

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Preeclampsia

Source: ClinicalTrials.gov NCT02610972 ↗

Enrolled (actual)

150

Serious AEs

0.0%

Results posted

Sep 2019

Primary outcomePrimary: Prevalence of Urine Congophilia Using Congo Red Test GV-005 — 87; 18 Participants

Summary

A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period

Outcome Measures

Outcome	Result	p-value
PRIMARY Prevalence of Urine Congophilia Using Congo Red Test GV-005	87; 18	—

Eligibility Criteria

Inclusion Criteria

Postpartum
Clinical diagnosis of preeclampsia (severe, mild or superimposed) including eclampsia (n=100) OR Clinically healthy (n=50)
Eligible to consent for research
Agree to comply with study procedures
Able to give informed consent

Exclusion Criteria

None

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02610972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.